Certified by Founder Lodge
NewLimit
United States - South San Francisco, California
START UP
1 Disclosed Funding Rounds $40,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic me
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 18 ,2023 | Series A | $40,000,000 | |
| May, 08 ,2025 | Series B | $130,000,000.00 |
Kleiner Perkins
Dimension
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
